IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

API business of Dr. Reddy’s reports rise in sales

4:44 AM MDT | July 31, 2013 | Deepti Ramesh

The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 6.1% rise in sales in the company’s fiscal first quarter, ended 30 June, compared with the year-ago quarter, to 5.86 billion Indian rupees ($96 million). Earnings figures for the PSAI business have not been disclosed. Growth in the business was muted because of fewer launch molecules to customers during the quarter, Dr. Reddy’s says. During the quarter, five drug master files (DMF) were filed globally...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa